Patents by Inventor Erika Bergsten

Erika Bergsten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In vivo stimulation of angiogenic activity
    Patent number: 6793918
    Abstract: Angiogenesis is stimulated by introducing two replication-deficient adenovirus vectors to the endothelial cells or proximate to the endothelial cells of an organism. The first vector encodes VEGF-B167 or a fragment or conservative substitution thereof, the second vector encodes VEGF-A or VEGF-C, or fragments or conservative substitutions thereof.
    Type: Grant
    Filed: November 1, 2001
    Date of Patent: September 21, 2004
    Assignees: Ludwig Institute for Cancer Research, Licentia, Ltd., Aventis Pharma SA
    Inventors: Berndt Enholm, Didier Branellec, Seppo Ylae-Herttuala, Ralf Pettersson, Erika Bergsten, Ulf Eriksson, Kari Alitalo, Aude Le Roux
  • In vivo stimulation of angiogenic activity
    Publication number: 20030165464
    Abstract: Angiogenesis is stimulated by introducing two replication-deficient adenovirus vectors to the endothelial cells or proximate to the endothelial cells of an organism. The first vector encodes VEGF-B167 or a fragment or conservative substitution thereof, the second vector encodes VEGF-A or VEGF-C, or fragments or conservative substitutions thereof.
    Type: Application
    Filed: November 1, 2001
    Publication date: September 4, 2003
    Inventors: Berndt Enholm, Didier Branellec, Seppo Ylae-Herttuala, Ralf Pettersson, Erika Bergsten, Ulf Eriksson, Kari Alitalo, Aude Le Roux